Details for 2012707745
Up to date per 02.04.2026
Actions
Details for 2012707745
Granted/Registered
European Patent
15.01.2014 A
15.04.2015 B1
07.03.2011
GB
201103836
A61K 47/48 20060101AFI20120928BHEP
Owner
GlaxoSmithKline Biologicals S.A.rue de l'Institut, 89 1330 RixensartBE
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
BIEMANS, Ralph LeonGlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 B-1330 RixensartBE
DUVIVIER, PierreGlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 B-1330 RixensartBE
GAVARD, Ollivier Francis NicolasGlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 B-1330 RixensartBE
Information about Fees